VIRTUAL CONFERENCE
From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, CFGI, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $545
This event will run approximately 8:45-4:40p (Eastern Time) each day.
Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110
3. Email your contact info to be invoiced to mtarman@acslive.com
| Agenda: DAY 1 | ||
|---|---|---|
| 8:45 | 10:10 | Accounting for R&D and Clinical Trials R&D Funding Arrangements R&D Cost Classifications SEC Comment Letter Trends |
| 10:10 | 10:25 | Break |
| 10:25 | 11:45 | ESG SEC & ISSB Updates Lessons learned from SOX ESG Governance and process Practical examples |
| 11:45 | 12:25 | Lunch Break |
| 12:25 | 1:40 | Gross to Net Introduction and Overview Industry View Estimation Methodology Approaching Launch Key Challenges SEC Comments Close and Financial Reporting GTN Hot Topics Discussion |
| 1:40 | 1:50 | Break |
| 1:50 | 3:05 | Tax Update Latest legislative developments Key Tax Proposals Build Back Better Act Observations Possible timing and other legislative priorities |
| 3:05 | 3:10 | Break |
| 3:10 | 4:40 | SEC & PCAOB Update Leadership Current Landscape Rulemaking Update CAQ regulations committee meeting highlights Emerging issues SEC Comments Resources |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:45 | 10:00 | Financial Accounting Update Current projects Presentation and disclosure projects Selected ASUs issued in 2022 |
| 10:00 | 10:10 | Break |
| 10:10 | 11:25 | Revenue Recognition Update Cases and examples Interaction of 808 and 606 Evaluating “active participation” Measure of progress SEC comment letter themes ASC 606 Implementation issues and lessons learned in the life science industry |
| 11:25 | 11:35 | Break |
| 11:35 | 12:55 | Automation in Life Sciences AI - where companies are finding best use Practical examples |
| 12:55 | 1:30 | Lunch Break |
| 1:30 | 3:00 | Fraud and Cybersecurity in Life Sciences Recent Trends Cases and Examples New threats from COVID Ransomware |
| 3:00 | 3:15 | Break |
| 3:15 | 4:30 | SOX & Internal Controls Update Management Review Controls Information Used in Controls (IUC) IT considerations SOX Optimization and Modernization |
| Conference Series Speakers Include: |
|---|
| Nathan Mitchell Deloitte, Partner |
| Tori Hack Ernst & Young, Senior Manager, ESG & Sustainability Services |
| Jenna Shintaku Ernst & Young, Audit Manager |
| Nick Lubold Deloitte, Manager |
| Storme Sixeas Deloitte, Senior Tax Manager |
| Christie Hutchinson Effectus Group, Director |
| Adam Barrow Effectus Group, Director |
| Dan Lujan Ernst & Young, Partner |
| Ryan Dolan CFGI, Life Sciences Leader and Regional Co-Managing Partner |
| Dan Sawicki CFGI, Senior Manager |
| Melanie Walker CFGI, Managing Director |
| Skyler Kersten Deloitte, Manager National Office Accounting Services |
| Taher Jamshidi Ernst & Young, Senior Manager |
| Kariuki Ndegwa Ernst & Young, Senior Manager |
| Michelle Chan Deloitte, Manager National Office Accounting Services |
| Katy Rossino Deloitte, Senior Manager National Office Accounting Services |
| Isaac Lawrence Thomas Deloitte, Manager National Office Accounting Services |
| Sarah Serufusa Ernst & Young, Senior Manager |
| Ron Johnson Ernst & Young, Senior Manager |
| Steve Abrahamson Ernst & Young, Executive Director |
| Sean Kennedy Deloitte, Audit Senior Manager |
| Abby Cohen Deloitte, Audit Senior Manager |